History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study

被引:70
作者
Calton, Brook A.
Chang, Shih Chen
Wright, Margaret E.
Kipnis, Victor
Lawson, Karla
Thompson, Frances E.
Subar, Amy F.
Mouw, Traci
Campbell, David S.
Hurwitz, Paul
Hollenbeck, Albert
Schatzkin, Arthur
Leitzmann, Michael F.
机构
[1] NIH, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, US Dept HHS, Bethesda, MD 20892 USA
[2] NCI, Div Canc Prevent, Biometry Res Grp, US Dept HHS,NIH, Bethesda, MD 20892 USA
[3] NCI, Div Canc Control & Populat Sci, Appl Res Program, US Dept HHS,NIH, Bethesda, MD 20892 USA
[4] Informat Management Serv Inc, Silver Spring, MD USA
[5] WESTAT Corp, Rockville, MD 20850 USA
[6] AARP, Washington, DC USA
关键词
prostate cancer; diabetes mellitus; prospective; cohort; incidence; AARP;
D O I
10.1007/s10552-007-0126-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective A history of diabetes has been hypothesized to decrease prostate cancer risk, but studies have not always considered confounding or effect modification by dietary or lifestyle factors. Methods We examined the association between diabetes history and subsequent prostate cancer risk in 328,316 men enrolled in the NIH-AARP Diet and Health Study. Participants were ages 50-71 years and without a prostate cancer diagnosis at baseline in 1995. A prior history of physician-diagnosed diabetes was assessed using a self-administered mailed questionnaire. Cases of prostate cancer were ascertained by matching the cohort to state cancer registries. Multivariable relative risks (RR) and 95% confidence intervals (CI) of prostate cancer were estimated using Cox regression. Results During 5 years and 1,432,676 person-years of follow-up, 11,193 prostate cancer cases were ascertained. The age-adjusted and multivariable RRs of prostate cancer comparing men with diabetes to those without diabetes were 0.69 (95% CI = 0.64, 0.74) and 0.71 (95% CI = 0.66, 0.76), respectively, indicating no important confounding. The inverse association between diabetes and prostate cancer was particularly strong among men in the highest category of routine physical activity at work or home (RR = 0.41; 95% CI = 0.23, 0.74; p value for test of interaction = 0.03). Findings were similar for organ-confined and advanced prostate cancer. Conclusion Results from this large prospective study suggest that a history of diabetes is associated with a decreased risk of prostate cancer. The relationship strengthened with high levels of routine physical activity. Because increased physical activity is associated with lower circulating levels of insulin and testosterone, our findings support a role of hypoinsulinemia and low androgenicity linking diabetes to decreased prostate cancer risk.
引用
收藏
页码:493 / 503
页数:11
相关论文
共 68 条
  • [1] CANCER RISK IN PATIENTS WITH DIABETES-MELLITUS
    ADAMI, HO
    MCLAUGHLIN, J
    EKBOM, A
    BERNE, C
    SILVERMAN, D
    HACKER, D
    PERSSON, I
    [J]. CANCER CAUSES & CONTROL, 1991, 2 (05) : 307 - 314
  • [2] *AJCC, 1997, CANC STAG MAN
  • [3] American Cancer Society, 2005, CANC FACTS FIG 2005
  • [4] Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study
    Batty, GD
    Shipley, MJ
    Marmot, M
    Smith, GD
    [J]. CANCER CAUSES & CONTROL, 2004, 15 (09) : 873 - 881
  • [5] BELL ET, 1957, AM J PATHOL, V33, P499
  • [6] Diabetes mellitus and risk of prostate cancer: a meta-analysis
    Bonovas, S
    Filioussi, K
    Tsantes, A
    [J]. DIABETOLOGIA, 2004, 47 (06) : 1071 - 1078
  • [7] Diabetes and benign prostatic hyperplasia progression in Olmsted County, Minnesota
    Burke, JP
    Jacobson, DJ
    McGree, ME
    Roberts, RO
    Girman, CJ
    Lieber, MM
    Jacobsen, SJ
    [J]. UROLOGY, 2006, 67 (01) : 22 - 25
  • [8] *CDCP, 2006, NAT DIAB SURV PROGR
  • [9] Centers for Disease Control and Prevention, 2005, MMWR-MORBID MORTAL W, V54, P991
  • [10] History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE™ (United States)
    Chan, JM
    Latini, DM
    Cowan, J
    DuChane, J
    Carroll, PR
    [J]. CANCER CAUSES & CONTROL, 2005, 16 (07) : 789 - 797